NYSE:ABTMedical Equipment
Abbott (ABT) Expands In Europe With Instinct CGM And Emerging Market Medicines
Abbott Laboratories (NYSE:ABT) is rolling out its Instinct continuous glucose monitoring sensor across Europe as part of MiniMed insulin pump systems.
The integration brings Abbott's CGM technology directly into new automated insulin delivery platforms for diabetes patients.
At the same time, Abbott is increasing its presence in emerging markets through biosimilar and branded generic medicine launches and regulatory approvals.
For investors watching Abbott Laboratories, these moves connect...